Heartburn Drugs May Higher Heart Attack Risk


Now you gotta see what antacid you use. There are different kind of antacids and while they all seems the same to you but there are different compositions to each antacid.Antacids with proton pump...

$650 Million Settlement: Pradaxa Case Settled for $650 Million


The U.S. litigation regarding Pradaxa has been settled for the hefty amount of $650 million. The fact was ceded by Boehringer Ingelheim. Pradaxa stands for dabigatran etexilate mesylate. The...

FDA Advisory Panel Votes In Favor Of Approval For Merck’s Vorapaxar


The FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-1 in favor of approval for vorapaxar, Merck's novel thrombin receptor antagonist. The “roller coaster ride” cliché might have...
    






Merck’s Vorapaxar Gets Positive FDA Review


A few years ago a novel antiplatelet agent from Merck seemed all but dead. Vorapaxar, a thrombin receptor antagonist, was widely thought to have no future after unacceptably high serious bleeding...